IHS Chemical Week

People & Business :: Companies

Metabolix Enacts Shareholder Rights Plan

3:09 PM MDT | July 7, 2009 | Vincent Valk

Metabolix (Cambridge, MA) has enacted a shareholder rights plan, the company announced today. The plan "ensures that shareholders receive fair treatment in the event of any coercive takeover attempt," says Metabolix CEO Richard Eno. However, it " was not adopted in response to any current effort to acquire control of the company," he adds. The plan includes a poison pill provision that takes effect in the event of an attempt to buy 15% or more of the company. The provision allows holders of common stock to exercise a right to purchase...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa